KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Exact Sciences (EXAS) Accumulated Depreciation & Amortization (2016 - 2025)

Exact Sciences (EXAS) has disclosed Accumulated Depreciation & Amortization for 16 consecutive years, with $576.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 20.03% to $576.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $576.6 million, a 20.03% increase, with the full-year FY2024 number at $508.6 million, up 21.9% from a year prior.
  • Accumulated Depreciation & Amortization was $576.6 million for Q3 2025 at Exact Sciences, up from $531.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $576.6 million in Q3 2025 to a low of $20.5 million in Q1 2021.
  • A 5-year average of $292.8 million and a median of $307.6 million in 2022 define the central range for Accumulated Depreciation & Amortization.
  • Biggest YoY gain for Accumulated Depreciation & Amortization was 519.02% in 2022; the steepest drop was 12.12% in 2022.
  • Exact Sciences' Accumulated Depreciation & Amortization stood at $214.8 million in 2021, then skyrocketed by 43.19% to $307.6 million in 2022, then skyrocketed by 35.64% to $417.2 million in 2023, then rose by 21.9% to $508.6 million in 2024, then increased by 13.38% to $576.6 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Accumulated Depreciation & Amortization are $576.6 million (Q3 2025), $531.0 million (Q1 2025), and $508.6 million (Q4 2024).